PPARG and brain disorder: Telmisartan and other ARBs are strongly neuroprotective in many rodent models of brain disorders, including TBI (35, 58–62) In experimental TBI, telmisartan reduced inflammation and neuronal injury and protected cognition (35, 63–71), effects mediated in part by activating PPARγ (32–35).